Logo.png
Singing Machine Signs License Agreement with Talpa Global for ‘The Voice’
April 09, 2019 09:00 ET | The Singing Machine Company, Inc.
Singing Machine and Talpa partner to create ‘The Voice Karaoke’ consumer products Fort Lauderdale, FL, April 09, 2019 (GLOBE NEWSWIRE) -- The Singing Machine Company, Inc. (“Singing Machine” or...
crab.jpg
The Boiling Crab® Expands into China with First Franchise License Agreement
January 29, 2019 19:00 ET | The Boiling Crab
GARDEN GROVE, Calif., Jan. 29, 2019 (GLOBE NEWSWIRE) -- The Boiling Crab®, popular for serving fresh, simply prepared seafood and shellfish in a casual environment, has finalized their first...
yield10.png
Yield10 Bioscience Exercises Option with University of Missouri to Obtain Exclusive Worldwide License to Advanced Technologies for Oilseed Crops
May 22, 2018 08:30 ET | Yield10 Bioscience, Inc.
WOBURN, Mass., May 22, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), a Company developing new technologies to achieve step-change improvements in crop yield to enhance global food...
NeutriSci and Lexaria Bioscience Enter Global Licensing Agreement
February 26, 2018 08:30 ET | NeutriSci International Inc.
VANCOUVER, British Columbia , Feb. 26, 2018 (GLOBE NEWSWIRE) -- – via NetworkWire - NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX-V:NU) (OTCQB:NRXCF) (Frankfurt:1N9) and...
yield10.png
Yield10 Bioscience Grants Research License to Monsanto to Evaluate Two Novel Yield Traits in Soybean
December 11, 2017 08:00 ET | Yield10 Bioscience, Inc.
WOBURN, Mass., Dec. 11, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced today that it has granted a non-exclusive research license to Monsanto Company to evaluate its novel...
Pathway Health Logo
Pathway Health Announces Exclusive INTERACT® License Agreement
October 18, 2016 09:00 ET | Pathway Health
WHITE BEAR LAKE, Minn., Oct. 18, 2016 (GLOBE NEWSWIRE) -- Pathway Health (www.pathwayhealth.com) announces they have entered into an exclusive licensing agreement with Florida Atlantic University...
Rhizen Pharmaceutica
Rhizen Pharmaceuticals Announces Exclusive Worldwide License Agreement for the Development and Commercialization of a Dual PI3K-delta gamma Inhibitor
December 09, 2015 07:00 ET | Rhizen Pharmaceuticals SA
La Chaux-de-Fonds, Switzerland , Dec. 09, 2015 (GLOBE NEWSWIRE) -- Rhizen Pharmaceuticals S.A. announced today that they have entered into an exclusive, worldwide license agreement with Novartis for...
RevoLaze
Crystal Apparel Becomes First Licensee in China of RevoLaze's Patented Technology
April 14, 2015 15:43 ET | RevoLaze
Cleveland, OH, April 14, 2015 (GLOBE NEWSWIRE) -- RevoLaze, LLC, a laser technology firm headquartered in Westlake, OH, announced today that it has reached a settlement and license agreement with...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals Announces Manufacturing and License Agreement for Twelve Generic Products
October 08, 2013 07:45 ET | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Oct. 8, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) announced today the signing of a Manufacturing and License Agreement ("Agreement")...
Penwest Enters Into Collaboration Agreement With Edison Pharmaceuticals
July 17, 2007 06:45 ET | Penwest Pharmaceuticals Co.
DANBURY, Conn., July 17, 2007 (PRIME NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) announced today that it has entered into a research, development, commercialization and license agreement...